Homepage Top Section 3 Archives - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

Close

Homepage Top Section 3

- Approvals
December 10, 2025

Health Canada approves Biogen’s Zurzuvae for PPD treatment

By Salong Debbarma

The once-daily oral therapy is administered as a 14-day course. Clinical trials demonstrated benefits from as early as day three, with significant symptom reduction by day 15, and
Approvals
Pharmaceuticals and Healthcare
Oncology
February 10, 2021

USFDA approves Libtayo for skin cancer treatment

By vbandhakavi

The US Food and Drug Administration (FDA) has approved Libtayo to be used for the treatment of patients having two of the most common skin cancers in the